Introducing Onsior – Effective Pain Relief For Cats And Dogs

First and only coxib class NSAID for both cats and dogs A new fast-acting pain reliever which concentrates at the site of inflammation Available as both an injectable solution and flavoured tablets Onsior®, the first and only coxib NSAID (non-steroidal anti-inflammatory drug) for the relief of pain and inflammation in both cats and dogs, will be launched by Novartis Animal Health on September 15th 2009. Traditionally, NSAIDs inhibit both COX-2 and COX-1 enzymes which can result in common side effects involving the gastrointestinal tract and the kidneys. Onsior, however, targets the pain-causing COX-2 enzymes while sparing the protective actions of COX-1 and is the only coxib licensed for cats as well as dogs. Tissue selectivity is a further benefit of Onsior. The drug travels rapidly through the bloodstream to the site of injury or irritation. It then concentrates at the point of inflammation, while exiting the bloodstream very quickly. Dosed once daily, Onsior has an excellent safety profile and fits different administration routes with pain and inflammatory indications, which are:

• An injectable solution for surgery (soft tissue in cats and soft tissue or orthopaedic surgery in dogs)
• Flavoured tablets, for pain and inflammation related to chronic osteoarthritis in dogs or acute pain and inflammation associated with musculoskeletal disorders in cats

Kelly Doucette, DVM, Global Technical Services Manager with Novartis Animal Health says: “With the benefits of being tissue selective, sparing COX-1, and having a short blood half-life – as well as being approved for both cats and dogs – Onsior will stand out as the new pain reliever of choice for vets.” Folkert Kamphuis, COO Novartis Animal Health adds: “Onsior covers multiple indications, works for cats and dogs, comes in two formulations – oral and injectable – and is very simple to dose, which allows veterinarians to use it as the cornerstone of pain management in their clinics. With this complete range, Onsior will offer to veterinarians a convenient solution addressing all their different needs.”

More from

• Animus launches SkinBond Multi for enhanced wound care
• IVC Evidensia reports 82% cut in Farm antibiotic use and 20% carbon emissions reduction
• Vet professionals flock to sign up to transformative locum platform
• The ProSalus Foundation launches urgent appeal for UK vets to support Ukrainian colleagues
• Vetsure Named Business of the Year at 2025 SME National Business Awards